Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

NRX Pharmaceuticals Inc. R (B1Q.F)

Compare
1.7500
-0.0100
(-0.57%)
At close: April 15 at 3:29:01 PM GMT+2
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
18,502
18,502
27,837
44,335
115,796
Operating Income
-18,502
-18,502
-27,837
-44,335
-115,796
Net Non Operating Interest Income Expense
-186
-186
374
249
-18
Other Income Expense
-6,438
-6,438
-2,687
4,332
22,751
Pretax Income
-25,126
-25,126
-30,150
-39,754
-93,063
Net Income Common Stockholders
-25,126
-25,126
-30,159
-39,754
-348,885
Diluted NI Available to Com Stockholders
-25,126
-25,126
-30,159
-39,754
-348,885
Basic EPS
-2.36
--
-3.98
-6.10
-74.40
Diluted EPS
-2.36
--
-3.98
-6.10
-74.40
Basic Average Shares
10,644.4610
--
7,576.1760
6,576.6780
4,691.7700
Diluted Average Shares
10,644.4610
--
7,576.1760
6,576.6780
4,691.7700
Total Operating Income as Reported
-18,502
-18,502
-27,837
-44,335
-115,796
Total Expenses
18,502
18,502
27,837
44,335
115,796
Net Income from Continuing & Discontinued Operation
-25,126
-25,126
-30,150
-39,754
-93,063
Normalized Income
-23,469
-23,469
-30,170
-44,591
-115,814
Interest Income
44
44
494
249
--
Interest Expense
230
230
120
--
18
Net Interest Income
-186
-186
374
249
-18
EBIT
-24,896
-24,896
-30,030
-39,754
-93,045
EBITDA
-24,891
-24,891
-30,025
-39,750
-93,043
Reconciled Depreciation
5
5
5
4
2
Net Income from Continuing Operation Net Minority Interest
-25,126
-25,126
-30,150
-39,754
-93,063
Total Unusual Items Excluding Goodwill
-1,657
-1,657
20
4,837
22,751
Total Unusual Items
-1,657
-1,657
20
4,837
22,751
Normalized EBITDA
-23,234
-23,234
-30,045
-44,587
-115,794
12/31/2021 - 5/27/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

0T20.F Traws Pharma, Inc.
0.0000
-100.00%
 
2X10.DU Abivax SA
5.10
+2.00%
 
BTTAY Biotest Aktiengesellschaft
24.23
0.00%
 
5LH0.F Guard Therapeutics International AB (publ)
1.0500
+4.48%
 
3EE0.F Kancera AB (publ)
0.0999
+20.51%
 
6JU0.F BioCardia, Inc.
0.0000
-100.00%
 
6DW.F D. Western Therapeutics Institute, Inc.
0.5900
-2.48%
 
5IU.F Isofol Medical AB (publ)
0.1477
+1.58%
 
2DE0.F Genprex, Inc.
0.0000
-100.00%
 
2I9.F Karolinska Development AB (publ)
0.0730
+42.30%